PE20061010A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING 4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-IL-5-THIO-BETA-D-XYLOPYRANOSIDE - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING 4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-IL-5-THIO-BETA-D-XYLOPYRANOSIDEInfo
- Publication number
- PE20061010A1 PE20061010A1 PE2006000188A PE2006000188A PE20061010A1 PE 20061010 A1 PE20061010 A1 PE 20061010A1 PE 2006000188 A PE2006000188 A PE 2006000188A PE 2006000188 A PE2006000188 A PE 2006000188A PE 20061010 A1 PE20061010 A1 PE 20061010A1
- Authority
- PE
- Peru
- Prior art keywords
- xylopyranoside
- benzopyran
- thio
- oxo
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE 4-METIL-2-OXO-2H-1-BENZOPIRAN-7-IL-5-TIO-BETA-D-XILOPIRANOSIDO CARACTERIZADO POR UN NIVEL DE ACTIVIDAD ANTI-IIa EN SITUACION DE EQUILIBRIO, DE AL MENOS 0,25-4 MICROGRAMOS DE UNIDADES DE SULFATO DE DERMATAN POR mL DE PLASMA DURANTE UN LARGO PERIODO DE TIEMPO DESPUES DE LA ADMINISTRACION ORAL Y UN PERFIL DE DISOLUCION EN EL QUE APROXIMADAMENTE EL 75% DE DICHO COMPUESTO SE LIBERA DESPUES DE 8 HORAS. DICHA COMPOSICION FARMACEUTICA ES GASTRORETENTIVO Y COMPRENDE ADEMAS UN POLIMERO HINCHABLE, UN POLIMERO MATRIZ Y UN AGENTE FLOTANTE PROPORCIONANDO MEJOR ABSORCION, EXPOSICION, BIODISPONIBILIDAD Y/O EFICACIA EN EL TRATAMIENTO DE TRASTORNOS TROMBOEMBOLICOSIT REFERS TO A PHARMACEUTICAL COMPOSITION CONTAINING 4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-IL-5-THIO-BETA-D-XYLOPYRANOSIDE CHARACTERIZED BY AN ANTI-IIa ACTIVITY LEVEL IN BALANCED SITUATION, OF AT LEAST 0.25-4 MICROGRAMS OF DERMATAN SULPHATE UNITS PER mL OF PLASMA OVER A LONG PERIOD OF TIME AFTER ORAL ADMINISTRATION AND A DISSOLUTION PROFILE IN WHICH APPROXIMATELY 75% OF SUCH COMPOUND IS RELEASED AFTER 8 . SAID PHARMACEUTICAL COMPOSITION IS GASTRORETENTIVE AND ALSO INCLUDES A INFLATABLE POLYMER, A MATRIX POLYMER AND A FLOATING AGENT PROVIDING BETTER ABSORPTION, EXPOSURE, BIO AVAILABILITY AND / OR EFFECTIVENESS IN THE TREATMENT OF THROMBOEM DISORDERS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65427905P | 2005-02-18 | 2005-02-18 | |
US69612105P | 2005-07-01 | 2005-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20061010A1 true PE20061010A1 (en) | 2006-11-11 |
Family
ID=36917125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000188A PE20061010A1 (en) | 2005-02-18 | 2006-02-16 | PHARMACEUTICAL COMPOSITIONS CONTAINING 4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-IL-5-THIO-BETA-D-XYLOPYRANOSIDE |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR054226A1 (en) |
PE (1) | PE20061010A1 (en) |
TW (1) | TW200640449A (en) |
WO (1) | WO2006089215A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69014064T2 (en) * | 1989-09-22 | 1995-05-18 | Fournier Ind & Sante | Benzopyranone beta-D-thioxyloside, process for its preparation and its therapeutic use. |
FR2801055B1 (en) * | 1999-11-17 | 2002-02-08 | Fournier Ind & Sante | BETA-D-5-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE |
-
2006
- 2006-02-16 PE PE2006000188A patent/PE20061010A1/en not_active Application Discontinuation
- 2006-02-16 AR AR20060100564A patent/AR054226A1/en not_active Application Discontinuation
- 2006-02-16 TW TW095105171A patent/TW200640449A/en unknown
- 2006-02-17 WO PCT/US2006/005821 patent/WO2006089215A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
TW200640449A (en) | 2006-12-01 |
AR054226A1 (en) | 2007-06-13 |
WO2006089215A2 (en) | 2006-08-24 |
WO2006089215A3 (en) | 2006-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2557988T3 (en) | Method to treat prostate diseases based on the local supply of active ingredients | |
MA27523A1 (en) | DELAYED CONTROLLED RELEASE FORMULATION | |
BRPI0500704A (en) | rehydratable personal care compositions | |
CR20150097A (en) | IMMUNOGENIC COMPOSITION | |
BRPI0412489A (en) | chewable confection composition releasing to the dental surfaces a unit dose of an enzyme | |
NZ598778A (en) | Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions | |
AR047841A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE-INFLAMMATORY DISORDERS | |
CL2011001735A1 (en) | Pharmaceutical composition comprising: a) the sglt2 inhibitor 1-chloro-4- (bd-glucopyranos-1-yl) -2- [4 - ((s) -tetrahydrofuran-3-yloxy) -benzyl] -benzene, b ) dppiv linagliptin inhibitor and c) a third antidiabetic agent that is metformin hydrochloride; and its use to treat type 2 diabetes mellitus. | |
ATE493973T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN | |
UY31295A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDED BY AN SGLT2 INHIBITOR | |
NO20075111L (en) | Pharmaceutical composition | |
PA8509001A1 (en) | DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL | |
BRPI0414876A (en) | pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses | |
BRPI0515645A (en) | therapeutic methods, compositions, compounds and uses of compounds | |
NO20062739L (en) | Controlled release of topirimate in liquid dosage form | |
RS54050B1 (en) | Formulations and methods for treating amyloidosis | |
CL2007003643A1 (en) | PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS. | |
ECSP10010052A (en) | GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN | |
BRPI0513133A (en) | pharmaceutical compositions containing diamino oxidase | |
PE20061245A1 (en) | COMPOSITIONS FOR ORAL TRANSMUCOUS TRANSMISSION OF METFORMIN | |
CL2007000789A1 (en) | Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease. | |
BRPI0611526A2 (en) | topical composition containing gelatin | |
UY26171A1 (en) | PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA | |
PE20061010A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-IL-5-THIO-BETA-D-XYLOPYRANOSIDE | |
AR047480A1 (en) | COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF OSEAS METABOLIC DISEASES; PROCESS OF PREPARATION AND USE OF THIS COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |